CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes Chief Scientific Officer gave up 875 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 834 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 999 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 2,361 shares (to pay taxes)
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes President and CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 875 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 834 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 969 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
Page 17 of 24 · 464 filings